Search clinical trials for: vasculitis remission

Total 2159 results

Chinese SLE Treatment And Research Group

Recruiting

Efficacy and Safety for Telitacicept in the Remission Maintenance Treatment of ANCA-associated Vasculitis (TTCAZAREM)

ANCA-associated Vasculitis | Maintenance Therapy

China
Chinese SLE Treatment And Research Group
Peking Union Medical College Hospital

Recruiting

Efficacy and Safety for Rituximab Combined With Telitacicept in the Treatment of ANCA-associated Vasculitis (TTCAAVREM)

ANCA Associated Vasculitis

China
Novartis Pharmaceuticals

Recruiting

Efficacy and Safety of Secukinumab in Patients With New Onset of Giant Cell Arteritis Who Are in Clinical Remission (GigAINt)

Giant Cell Arteritis

Germany
Assistance Publique - Hôpitaux de Paris
URC-CIC Paris Descartes Necker Cochin; French Vasculitis Study Group

Recruiting

Study of Mepolizumab-based Regimen Compared to Conventional Therapeutic Strategy in Patients With Eosinophilic Granulomatosis With Polyangiitis (E-merge) (E-merge)

Eosinophilic Granulomatosis With Polyangiitis

France
Leiden University Medical Center

Recruiting

Exploring Durable Remission With Rituximab in Antineutrophil Cytoplasmic Antibody(ANCA)-Associated Vasculitis (ENDURRANCE-1)

ANCA Associated Vasculitis

Netherlands
Hospices Civils de Lyon

Recruiting

Evaluate the Remission MAINtenance Using Extended Administration of Prednisone in Systemic Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis. (MAINEPSAN)

Granulomatosis With Polyangitis

France
Mayo Clinic
Genentech, Inc.

Terminated

PR3-AAV Resilient Remission or PRRR

Microscopic Polyangiitis | Granulomatosis With Polyangiitis | ANCA Associated Vasculitis

United States
University of Bonn

Active, not recruiting

Methotrexate as Remission Maintenance Therapy After Remission-Induction With Tocilizumab and Glucocorticoids in Giant Cell Arteritis (MTXinGCA)

Giant Cell Arteritis

Germany
University of Pennsylvania
National Heart, Lung, and Blood Institute (NHLBI); National Institute of Arthritis... and other collaborators

Active, not recruiting

The Assessment of Prednisone In Remission Trial - Centers of Excellence Approach (TAPIR)

Granulomatosis With Polyangiitis

United States, Canada
Massachusetts General Hospital

Terminated

Maintenance of ANCA Vasculitis Remission by Intermittent Rituximab Dosing (MAINTANCAVAS)

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

United States
University of South Florida
National Heart, Lung, and Blood Institute (NHLBI); National Institute of Arthritis... and other collaborators

Active, not recruiting

The Assessment of Prednisone In Remission Trial (TAPIR) - Patient Centric Approach (TAPIR)

Vasculitis | Granulomatosis With Polyangiitis | Wegener Granulomatosis

United States
Assistance Publique - Hôpitaux de Paris
French Vasculitis Study Group

Active, not recruiting

Maintenance of Remission With Rituximab Versus Azathioprine for Newly-diagnosed or Relapsing Eosinophilic Granulomatosis With Polyangiitis. (MAINRITSEG)

Eosinophilic Granulomatosis With Polyangiitis

France
Assistance Publique - Hôpitaux de Paris
French Vasculitis Study Group

Completed

Rituximab in Eosinophilic Granulomatosis With Polyangiitis (REOVAS)

Eosinophilic Granulomatosis With Polyangiitis (EGPA)

France
Medical University of Vienna

Completed

A Study to Evaluate the Efficacy of Tocilizumab as a Remission-Induction and Glucocorticoid-Sparing Regimen in Subjects With New-Onset Polymyalgia Rheumatica (PMR- SPARE)

Polymyalgia Rheumatica

Austria
Human Genome Sciences Inc., a GSK Company
GlaxoSmithKline

Completed

Belimumab in Remission of VASculitis (BREVAS)

Vasculitis

United States, Australia, France, Spain, Italy, Peru, Belgium, Canada, Germany, Romania, Mexico, United Kingdom, Hungary, Ireland, Poland, Switzerland, Czechia, Russian Federation, Norway, Sweden
Assistance Publique - Hôpitaux de Paris

Completed

Comparison Study of Two Rituximab Regimens in the Remission of ANCA Associated Vasculitis (MAINRITSAN 2)

Microscopic Polyangiitis | Granulomatosis With Polyangiitis | Renal Limited Forms

France
Assistance Publique - Hôpitaux de Paris

Completed

Efficacy Study of Two Treatments in the Remission of Vasculitis (MAINRITSAN)

Microscopic Polyangiitis | Wegener Granulomatosis

France
Hospital of Prato

Unknown

Tocilizumab Dose-tapering and Interruption in Patients With Giant Cell Arteritis Achieving the Clinical Remission.

Giant Cell Arteritis

Italy
Anthera Pharmaceuticals

Withdrawn

BIANCA-SC: A Study of the Efficacy, Safety, and Tolerability of Blisibimod in Addition to Methotrexate During Induction of Remission in Subjects With ANCA-Associated Small Vessel Vasculitis (BIANCA-SC)

Microscopic Polyangiitis | Granulomatosis With Polyangiitis
University of Genova

Completed

Short Term Efficacy of a Starting Dose of 12.5 mg of Prednisone in Polymyalgia Rheumatica Patients

Polymyalgia Rheumatica

Italy
University of Parma

Unknown

Cyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing Vasculitides

Wegener's Granulomatosis | Microscopic Polyangiitis | Churg-Strauss Syndrome | Polyarteritis Nodosa

Italy
National Institute of Allergy and Infectious Diseases...

Completed

Etanercept to Treat Wegener's Granulomatosis

Vasculitis | Wegener's Granulomatosis

United States
National Institute of Allergy and Infectious Diseases...

Completed

Comparison of Treatments to Maintain Disease Remission in Patients With Wegener's Granulomatosis and Related Vasculitis Syndromes

Vasculitis | Wegener's Granulomatosis

United States
National Institute of Allergy and Infectious Diseases...

Completed

An Open Label Pilot Study Examining the Use of Rituximab in Patients With Wegener's Granulomatosis Who Have Experienced Disease Relapse on Standard Therapies

Wegener's Granulomatosis

United States
National Institute of Allergy and Infectious Diseases...

Completed

Cyclophosphamide and Prednisone Followed by Methotrexate To Treat Vasculitides

Vasculitis | Wegener's Granulomatosis

United States
Cambridge University Hospitals NHS Foundation Trust

Completed

Pulse Versus Continuous Cyclophosphamide for Induction of Remission in ANCA-Associated Vasculitides

Wegener's Granulomatosis | Microscopic Polyangiitis | ANCA Associated Systemic Vasculitis
Xiao-Ming Mao
National Natural Science Foundation of China

Not yet recruiting

Graves' Disease Induced by Epstein-Barr Virus Lytic Reactivation

Graves Disease | Epstein-Barr Virus | Graves' Disease in Remission

China
Peking University People's Hospital
Akeso Pharmaceuticals, Inc.

Not yet recruiting

Neoadjuvant Cadonilimab Combined With Anlotinib in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma

Locally Advanced Esophageal Squamous Cell Carcinoma
First Affiliated Hospital of Wenzhou Medical University
Shanghai First Song Therapeutics Co., Ltd

Not yet recruiting

The Safety and Efficacy of Anti-CD19 CAR-T Cells in Patients With Relapsed/Refractory Autoimmune Diseases

Systemic Sclerosis | Sjogren's Syndrome | Antiphospholipid Syndrome | ANCA Associated Vasculitis | Systemic Lupus Erythematosus (SLE) | Inflammatory Myopathy

China
Peking Union Medical College Hospital
Central South University; Zhejiang University; Beijing Children's Hospital; Shenzhen... and other collaborators

Recruiting

Observational Study of Pediatric Rheumatic and Immunologic Diseases in China: The CAPRID Registry

Autoimmune Diseases | Autoinflammatory Diseases

China
Umm Al-Qura University

Recruiting

"Comparative Effect of Different Drugs Used to Tr€at Patients in Rheumatoid Arthritis Saudi Database (RASD)"

Rheumatoid Arthritis RA
Centre Hospitalier Universitaire de Nīmes

Not yet recruiting

Prevalence and Characteristics of Intimate Partner Violence Against Individuals Seeking Hematological Consultations (HEMATO-WAST)

Intimate Partner Violence | Pulmonary Embolism and Thrombosis | Deep Vein Thrombosis (DVT)/Thrombophlebitis

France
Celgene

Not yet recruiting

Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis

Multiple Sclerosis, Relapsing-Remitting

United States
The Hong Kong Polytechnic University

Recruiting

Vulnerability Markers for Depression

Healthy | Major Depressive Disorder | Major Depressive Disorder Remission

Hong Kong
Novartis Pharmaceuticals

Not yet recruiting

Iptacopan in Patients With ANCA Associated Vasculitis

Anti-Neutrophil Cytoplasm Antibodies (ANCA) Associated Vasculitis
Soligenix

Not yet recruiting

Dusquetide for the Treatment of Behcet's Disease

Behçet Disease

Turkey
Yonsei University

Recruiting

Intestinal Ultrasound, Magnetic Resonance Enterography, and Conventional Assessment Tools Before and After Treatment of Intestinal Behcet's Disease

Intestinal Behcet Disease

Korea, Republic of
Universitaire Ziekenhuizen KU Leuven

Recruiting

Pediatric Eosinophilic Esophagitis (pedEoE): Effect of Allergen Heat Denaturation on EoE Remission: a Pilot Trial

Eosinophilic Esophagitis

Belgium
China Immunotech (Beijing) Biotechnology Co., Ltd.
Shanghai Changzheng Hospital

Not yet recruiting

An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease

Systemic Lupus Erythematosus | Systemic Sclerosis | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | Sjogren's Syndrome | Antiphospholipid Syndrome | Inflammatory Myopathy
Hospital Universitario Marqués de Valdecilla

Recruiting

Effects of Topical Sesame Oil in the Prevention of Peripheral Venous Catheter Phlebitis: Clinical Trial.

Phlebitis

Spain
Shanghai Changzheng Hospital

Recruiting

Anti-CD19-CD3E-CAR-T Cells in Relapsed/Refractory Autoimmune Disease

Systemic Sclerosis | Sjogren's Syndrome | Antiphospholipid Syndrome | ANCA Associated Vasculitis | Systemic Lupus Erythematosus (SLE) | Inflammatory Myopathy

China
Showa Inan General Hospital

Recruiting

Association Between LRG and Histologic Remission in Ulcerative Colitis

Ulcerative Colitis in Histologic Remission

Japan
Chugai Pharmaceutical

Not yet recruiting

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

Antiphospholipid Syndrome (APS) | Immune Thrombocytopenia (ITP) | Dermatomyositis (DM) | Bullous Pemphigoid (BP) | Behçet's Syndrome (BS) | Immune-mediated Necrotizing Myopathy (IMNM)

United States, Japan
Korean Society of Hematology

Not yet recruiting

A Study of Treatment-free Remission in Chronic Phase Chronic Myeloid Leukemia (AsterA)

Chronic Myeloid Leukemia, Chronic Phase
Ping An

Not yet recruiting

Evaluation of Enteral Nutrition Biscuits for Inducing Remission in Moderate-to-severe Crohn's Disease

Crohn's Disease
Essen Biotech

Not yet recruiting

Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE) (BAH242)

Autoimmune Diseases | Systemic Lupus Erythematosus | Systemic Sclerosis | Lupus Nephritis | Microscopic Polyangiitis | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | Sjogren's Syndrome | Idiopathic Inflammatory Myopathies | Granulomatous Polyangiitis

China
Jie Zhong

Not yet recruiting

Intraoperative Application of Fluorescein Sodium Angiography in Vascular Retinopathy

Diabetic Retinopathy | Retinal Vein Occlusion | Vitreous Hemorrhage | Retinal Vasculitis | Vascular Retinopathy of Left Eye (Disorder) | Vascular Retinopathy of Right Eye (Disorder)
Insel Gruppe AG, University Hospital Bern
Paul Scherrer Institut, Center for Proton Therapy

Not yet recruiting

A Clinical Trial to Investigate 18F-AzaFol in the Diagnosis of Large Vessel Vasculitis (CRAFT)

Giant Cell Arteritis

Switzerland
Azienda Ospedaliero, Universitaria Pisana

Not yet recruiting

Deciphering the Role of Incretin Hormones in Weight Loss-induced Remission of Type 2 Diabetes (DIABeat) (DiabEATit)

Obesity | Diabetes Mellitus Type 2 in Obese

Italy
Novartis Pharmaceuticals

Recruiting

Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR) (REPLENISH-EXT)

Polymyalgia Rheumatica

Australia

Search clinical trials for: vasculitis remission

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malaysia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations